Register for real-time alerts, custom portfolio, and market movers
The current RV6 market cap is 8.01B. The company's latest EPS is USD 0.4341 and P/E is 387.86.
| Year End 28 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.92B | 3.54B | 3.98B | 4.13B | 4.05B |
| Operating Income | 432.73M | 589.86M | 650.98M | 617.26M | 227.35M |
| Net Income | 364.3M | 390.98M | 486.23M | 474.62M | 22.2M |
| Year End 28 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.49B | 7.02B | 7.6B | 8.2B | 7.53B |
| Total Liabilities | 3.35B | 4.43B | 4.58B | 4.54B | 4.02B |
| Total Equity | 2.12B | 2.54B | 2.98B | 3.6B | 3.47B |
| Year End 28 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 546.58M | 760.8M | 619.64M | 683.9M | 734.58M |
| Investing | -601.54M | -1.44B | -607.92M | -563.16M | -245.09M |
| Financing | 47.25M | 672.6M | -42.4M | -85.52M | -550.93M |
| Market Cap | 8.01B |
| Price to Earnings Ratio | 387.86 |
| Price to Sales Ratio | 2.13 |
| Price to Cash Ratio | 44.25 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 51.14M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.55 (1%) |
| Company Name | Charl Riv Labs Intl Dl 1 |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.criver.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
